News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Master Regulator That Drives Majority of Lymphoma Discovered, Weill Cornell Medical College Study


5/14/2013 7:10:20 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

A soon-to-be-tested class of drug inhibitors were predicted to help a limited number of patients with B-cell lymphomas with mutations affecting the EZH2 protein. However, a research team, led by investigators at Weill Cornell Medical College, now report that these agents may, in fact, help a much broader cross section of lymphoma patients.

Hey, check out all the research scientist jobs. Post your resume today!

Read at ScienceDaily
Read at MedicalXpress
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES